European grant for preemie formula

Israel’s ELGAN (see here previously) has been awarded a $2.5 million grant by the European Innovation Council (EIC). It will help ELGAN clinically test its ELGN-GI oral formula for the treatment of intestinal malabsorption that prevents preterm infants from absorbing nutrients.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *